The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger.

Novo stock prices fell by more than 3% when the ... GLP-1 drugs were selected for the government price-setting program: Ozempic injections for Type 2 diabetes, Wegovy shots for obesity, and ...

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%. Novo Nordisk said a Phase 1b/2a clinical trial of amycretin ...

Scientists may have found a way to help the body naturally produce more of an Ozempic-like hormone ... including GLP-1. Main image, a stock image of a hungry man craving sweet food.

A pharmacist holds a box of Novo Nordisk A/S Ozempic brand semaglutide medication arranged at a pharmacy in Provo, Utah, Nov. 27, 2023. George Frey/Bloomberg via Getty Images, FILE The newly ...

Novo Nordisk makes both Ozempic and Wegovy, which have become popular for weight-loss. - Photo: Kevin Mohatt for The Washington Post (Getty Images) The Centers for Medicare & Medicaid Services ...

One reason is pressure from American drugmaker Eli Lilly, which makes competing products Zepbound and Mounjaro (alternatives to Wegovy and Ozempic, respectively). Novo’s stock fell slightly in ...